SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-671804
Filing Date
2016-08-04
Accepted
2016-08-04 16:10:59
Documents
42
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d225676d10q.htm 10-Q 551854
2 EX-10.2 d225676dex102.htm EX-10.2 75527
3 EX-31.1 d225676dex311.htm EX-31.1 6353
4 EX-31.2 d225676dex312.htm EX-31.2 5870
5 EX-32.1 d225676dex321.htm EX-32.1 4171
  Complete submission text file 0001193125-16-671804.txt   2056513

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT drna-20160630.xml EX-101.INS 276824
7 XBRL TAXONOMY EXTENSION SCHEMA drna-20160630.xsd EX-101.SCH 23780
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20160630_cal.xml EX-101.CAL 34200
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20160630_def.xml EX-101.DEF 64311
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20160630_lab.xml EX-101.LAB 186671
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20160630_pre.xml EX-101.PRE 126198
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 161807521
SIC: 2834 Pharmaceutical Preparations